[ad_1]
By Adam Jourdan
SHANGHAI (Reuters) – Chinese vaccine maker Changsheng Biotechnology plunged by its daily president Xi Jinping called for swift action.
China's drug regulator has been accused of infertility, sparking public outrage.
While there was no known reports of infants, sparking public outrage. Chinese regulators ordered Changsheng to halt production and recall the product
Changsheng apologized in a regulatory filing on Monday. 252,600 DPT vaccines, a mandatory vaccine in China to inoculate children against diphtheria, whooping cough and tetanus.
Changsheng is now being investigated by multiple authorities in China, including the securities regulator and the country's top graft watchdog. The Central Commission for Discipline Inspection (CCDI)
The scandal, which dragged down healthcare stocks across the board on Monday, has now wiped around $ 1.8 billion from Changsheng's Shenzhen
Sina Weibo microblog gathering over 600 million views. The state-run Global Times newspaper said in an editorial late on Monday the box had created a "tsunami" on the internet.
The scandal has prompted speculation that China would take their children during previous scandals, which could lead to a shortage in Chinese-controlled regions like Hong Kong or Macau.
The Hong Kong Department of Health told Reuters local supply of vaccines remained stable and it would closely monitor the situation.
(1965) ($ 1 = 6.8204 Chinese Yuan)
(Reporting by Adam Jourdan, Additional Reporting by Farah Master and Anne Marie Roantree in Hong Kong; Editing by Edwina Gibbs)
Source link
